[The effect of guanethidine and bretylium on the liberation of pyrocatecholamines].
D000311:Adrenal Glands / Q000378:metabolism*; D000578:Amidines / Q000494:pharmacology*; D000928:Antidepressive Agents / Q000494:pharmacology*; D001949:Bretylium Compounds; D002395:Catecholamines / Q000378:metabolism*; D006145:Guanethidine; D013565:Sympatholytics / Q000494:pharmacology*
D000578:Amidines; D000928:Antidepressive Agents; D001949:Bretylium Compounds; D002395:Catecholamines; D013565:Sympatholytics; C045166:bretylium; D006145:Guanethidine
ADRENAL GLANDS/metabolism; AMIDINES/pharmacology; ANTIDEPRESSIVE AGENTS/pharmacology; CATECHOLAMINES/metabolism; SYMPATHOLYTICS/pharmacology